Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marcos Amuchástegui is active.

Publication


Featured researches published by Marcos Amuchástegui.


Echocardiography-a Journal of Cardiovascular Ultrasound and Allied Techniques | 1996

Atrial Mechanical Function Before and After Electrical or Amiodarone Cardioversion in Atrial Fibrillation: Assessment by Transesophageal Echocardiography and Pulsed Doppler.

Luis Maria Amuchastegui; Cecilia Cravero; Oscar Salomone; Marcos Amuchástegui

In some patients with atrial fibrillation (AF), it has been suggested that left atrial mechanical dysfunction can develop after successful electrical cardioversion, justifying postcardioversion anticoagulant treatment. The purpose of this study was to investigate differences in left atrial appendage peak flow velocities and the incidence of left atrial spontaneous echo contrast in patients with AF before and after electrical cardioversion or intravenous amiodarone, studied using transesophageal echocardiography (TEE) and pulsed Doppler. We performed a control TEE in 7 patients in the electrical group and 6 in the amiodarone group, with no significant clinical differences between both groups. A second TEE was performed immediately in the 7 patients with successful electrical cardioversion. The peak flow velocities in the appendage before and after the procedure were: filling 43.3 ± 22 vs 27.7 ± 28 cm/sec (P = 0.01) and emptying 35.5 ± 22 vs 23.6 ± 17 cm/sec (P = 0.01), respectively. The spontaneous echo contrast increased in 4 of the 7 patients. In 4 patients of the amiodarone group, the peak flow velocities in the appendage during AF and within the first 24 hours after restoration of sinus rhythm were: filling 37.4 ± 12 vs 37.8 ± 18 cm/sec and emptying 36.4 ± 18 vs 35.9 ± 18 cm/sec, respectively (P = NS). There was no change in spontaneous echo contrast. In conclusion, patients with AF reverted to sinus rhythm using amiodarone did not show changes in left atrial mechanical function; however, patients with electrical cardioversion showed mechanical dysfunction. Further investigations on the effects of amiodarone and other drugs on the mechanical function of the atria are needed to determine if patients reverted pharmacologically require antico‐agulation post reversion.


Echocardiography-a Journal of Cardiovascular Ultrasound and Allied Techniques | 1994

Embolic Accident Following Heparin Therapy for a Left Ventricular Clot Diagnosed by TEE

Luis Maria Amuchastegui; Marcos Amuchástegui; Eduardo Moreyra; Oscar Salomone

There are few data available on the incidence of embolic events inpatients with systemic anticoagulation. We describe a 40‐year‐old woman in congestive heart failure who was shown by transesophageal echocardiography to have an apical thrombus in the left ventricle without concomitant aneurysm. The patient was started on heparin immediately after the diagnosis was established. Twelve hours later she developed an embolic cerebrovascular accident. We believe that heparin dislodged the thrombus as occurs occasionally with thrombolytic agents used in the treatment of acute myocardial infarction.


Journal of Heart and Lung Transplantation | 2004

Using polymerase chain reaction in early diagnosis of re-activated Trypanosoma cruzi infection after heart transplantation

Cecilia Maldonado; Susana Albano; Lorena Vettorazzi; Oscar Salomone; Juan Carlos Zlocowski; Claudio Abiega; Marcos Amuchástegui; Roque Córdoba; Teresita Alvarellos


American Journal of Cardiology | 1997

Human chagasic disease is not associated with an antiheart humoral response

M.Kamran Baig; Oscar Salomone; Alida L.P. Caforio; Jonathan H Goldman; Marcos Amuchástegui; Tomàs Caiero; William J McKenna


Journal of Heart and Lung Transplantation | 2004

Using polymerase chain reaction in early diagnosis of re-activated infection after heart transplantation

Cecilia Maldonado; Stephen S. Albano; L. A. Vettorazzi; Oscar Salomone; Juan Carlos Zlocowski; Claudio Abiega; Marcos Amuchástegui; Roque Córdoba; T. de Alvarellos


Rev. argent. cardiol | 2003

Morbimortalidad de los pacientes con miocardiopatía chagásica y trasplante cardíaco. Experiencia inicial

Fernando M Urinovsky; Oscar Salomone; Alan J Zazu; Alejandro Martínez Colombres; Juan C Zlocowsky; Teresita Alvarellos; Ana Diller; Marcos Amuchástegui


Revista chilena de cardiología | 2018

Desproporción prótesis-paciente luego de reemplazo de válvula aórtica y seguimiento a 6 años

Carolina Carrizo; Virginia Figueroa; Gabriela Vilte; Nicolás Egea; Juan González Grima; Brunella Bertazzo; Eduardo J. Brenna; Marcos Amuchástegui; Alejandro Contreras


Revista Argentina de Cardiología | 2015

Anticoagulación oral con antagonistas de la vitamina K en tiempos de los nuevos anticoagulantes

Tomás Amuchástegui; José I. Revigliono; Marcos Amuchástegui; Alejandro Contreras


Argentine Journal of Cardiology | 2015

Oral Anticoagulation with Vitamin K Antagonists in the Era of New Anticoagulants

Tomás Amuchástegui; José I. Revigliono; Marcos Amuchástegui; Alejandro Contreras


Insuficiencia cardíaca | 2013

Correlación de los parámetros ecocardiográficos de estenosis aórtica en pacientes con fracción de eyección normal

Alejandro Contreras; Roberto A. Chamale; Eduardo J. Brenna; Gustavo R. Parisi; Marcos Amuchástegui

Collaboration


Dive into the Marcos Amuchástegui's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Luis Maria Amuchastegui

National University of Cordoba

View shared research outputs
Top Co-Authors

Avatar

Roberto Madoery

Catholic University of Cordoba

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eduardo Moreyra

National University of Cordoba

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge